Abstract
AbstractThis chapter focuses on the interaction of domestic regulation of corruption in China and Hong Kong and the increasing number of international arbitration cases brought by and against China. In conjunction with the enormous growth in foreign investment in China since it opened up at the end of the 1970s, China has developed a comprehensive network of international investment agreements (IIAs). Hong Kong is also a party to about 30 IIAs in its own name. Government and business corruption and bribery have been a problem in both jurisdictions. China and Hong Kong have taken active steps to criminalize, and to investigate and prosecute, corruption and to participate in major international initiatives relating to corruption. While corruption has, so far, made a limited appearance in the small number of investor–state dispute settlement (ISDS) cases brought by investors against China and cases brought against other states by Chinese and Hong Kong investors, based on existing material, a number of tentative conclusions and recommendations can be made. China should move towards a higher level of transparency, both in relation to ISDS cases and to its domestic criminal law system; both China and Hong Kong should play a more active role in prosecuting bribery by enterprises outside China, including by joining the OECD Convention on Combating Bribery of Foreign Officials; and, finally, China should consider including provisions relating to corruption in its future IIAs in order to demonstrate its commitment to the international war on corruption in business.
Publisher
Springer Nature Singapore
Reference79 articles.
1. ABC (2021) China Formally Applies for CPTPP after Lobbying Australia, 17 September 2021. https://www.abc.net.au/news/2021-09-17/china-applies-to-join-cptpp/100469342
2. Bath, V. (2011) The Quandary for Chinese Regulators: Controlling the Flow of Investment into and out of China. In: V. Bath and L. Nottage (eds) Foreign Investment and Dispute Resolution Law and Practice in Asia. Routledge, London, pp 68–89
3. Bath, V. (2012) China, International Business, and the Criminal Law. Asian-Pacific Law & Policy Journal 13 (1): 1–35
4. Bath, V. (2020) China’s Role in the Development of International Investment Law – from Bystander to Participant. Asian Journal of WTO and International Health Law 15: 359–397
5. BBC (2014) GlaxoSmithKline fined $490m by China for Bribery, 19 September 2014. https://www.bbc.com/news/business-29274822
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献